Shock and Hemodynamic Monitoring — Septic, Cardiogenic, and Hypovolemic Shock

Shock is a life-threatening condition characterized by inadequate tissue perfusion and oxygen delivery, resulting in cellular dysfunction and metabolic acidosis. [KEY_CONCEPT] Understanding the pathophysiologic mechanisms underlying different shock states is critical for appropriate management.

Classification of Shock States

Hypovolemic shock results from intravascular volume depletion due to hemorrhage, dehydration, or third-spacing. Compensatory mechanisms include tachycardia, vasoconstriction, and increased myocardial contractility.

Cardiogenic shock occurs when the heart cannot maintain adequate cardiac output despite normal preload. Primary causes include acute MI, decompensated heart failure, and mechanical complications. [HIGH_YIELD] The Frank-Starling mechanism is exhausted, leading to pulmonary edema and systemic hypoperfusion.

Septic shock represents the most severe form of sepsis, characterized by profound vasodilation, increased vascular permeability, and myocardial depression. [CLINICAL_PEARL] Early septic shock may present with high cardiac output and low SVR, while late shock demonstrates myocardial dysfunction with reduced cardiac output.

Hemodynamic Parameters

Key hemodynamic variables include:

• Cardiac Output (CO): 4-8 L/min
• Cardiac Index (CI): 2.5-4.0 L/min/m²
• Systemic Vascular Resistance (SVR): 800-1200 dynes·sec/cm⁵
• Pulmonary Capillary Wedge Pressure (PCWP): 6-12 mmHg
• Mixed Venous Oxygen Saturation (SvO₂): 65-75%

Universal Signs of Shock

[HIGH_YIELD] All shock states share common clinical features reflecting inadequate tissue perfusion:

• Altered mental status: Confusion, agitation, or obtundation
• Hypotension: SBP <90 mmHg or MAP <65 mmHg
• Tachycardia: HR >100 bpm (may be absent in beta-blocked patients)
• Oliguria: Urine output <0.5 mL/kg/hr
• Cool, clammy extremities: Delayed capillary refill >3 seconds
• Metabolic acidosis: Lactate >2 mmol/L

Shock-Specific Clinical Features

Hypovolemic Shock

• History: Bleeding, vomiting, diarrhea, burns, diuretic use
• Physical exam: Flat neck veins, dry mucous membranes, orthostatic hypotension
• Laboratory: Hemoconcentration (↑ Hgb/Hct), ↑ BUN/Cr ratio >20:1

Cardiogenic Shock

• History: Chest pain, dyspnea, known CAD or heart failure
• Physical exam: Elevated JVP, S3 gallop, pulmonary rales, peripheral edema
• Diagnostic: ECG changes, elevated troponins, BNP/NT-proBNP
• [CLINICAL_PEARL] Cardiogenic shock complicates 5-10% of STEMIs and carries 50% mortality

Septic Shock

• History: Fever, chills, recent infection, immunocompromised state
• Physical exam: Hyperthermia or hypothermia, warm extremities (early), source identification
• Laboratory: Leukocytosis or leukopenia, bandemia, elevated lactate, procalcitonin

Hemodynamic Assessment

Non-invasive monitoring:

• Arterial blood pressure (manual vs automated)
• Pulse pressure variation in mechanically ventilated patients
• Echocardiography for cardiac function assessment

Invasive monitoring (when indicated):

• Arterial catheterization for continuous BP monitoring
• Central venous catheterization for CVP and ScvO₂
• Pulmonary artery catheterization (Swan-Ganz) in complex cases
• [HIGH_YIELD] Pulse contour analysis devices (FloTrac, PiCCO) for continuous cardiac output monitoring

Initial Diagnostic Workup

Essential Laboratory Studies

• Complete blood count: Hemoglobin, platelet count, WBC with differential
• Basic metabolic panel: Electrolytes, BUN, creatinine, glucose
• Arterial blood gas: pH, PaCO₂, PaO₂, lactate, base deficit
• Liver function tests: AST, ALT, bilirubin, albumin
• Coagulation studies: PT/INR, PTT, fibrinogen, D-dimer
• Cardiac biomarkers: Troponin I/T, BNP/NT-proBNP
• Inflammatory markers: CRP, procalcitonin, ESR

Diagnostic Algorithm for Undifferentiated Shock

Patient presents with shock (MAP <65 mmHg + organ dysfunction) | v Obtain focused history & physical exam | v Initial labs: CBC, BMP, ABG, lactate, troponin | v Bedside echocardiography + chest X-ray | +-----------+----------+ | | v v Hyperdynamic Hypodynamic (EF >55%) (EF <45%) | | v v Distributive Cardiogenic

• Septic - Acute MI
• Anaphylactic - Heart failure
• Neurogenic - Mechanical | | v v Blood cultures Coronary angiography Source control Mechanical support

Sepsis-3 Criteria for Septic Shock

[KEY_CONCEPT] Septic shock is defined by:

Clinical Criteria:

• ✓ Sepsis (SOFA score ≥2 points)
• ✓ Vasopressor requirement to maintain MAP ≥65 mmHg
• ✓ Lactate >2 mmol/L (18 mg/dL)
• ✓ Despite adequate fluid resuscitation

Advanced Hemodynamic Assessment

Pulmonary Artery Catheter Indications

• Cardiogenic shock with uncertain etiology
• Complex shock states (mixed pathophysiology)
• Refractory shock despite initial management
• Need for precise fluid balance in heart failure

[CLINICAL_PEARL] Thermodilution cardiac output remains the gold standard but requires proper technique and interpretation of waveforms.

Dynamic Parameters for Fluid Responsiveness

• Pulse pressure variation (PPV): >13% suggests fluid responsiveness
• Stroke volume variation (SVV): >10-15% indicates preload dependence
• Passive leg raise test: 10% increase in CO suggests fluid responsiveness
• [HIGH_YIELD] Static parameters (CVP, PCWP) are poor predictors of fluid responsiveness

General Shock Management Principles

Initial Resuscitation (First Hour)

1. Airway and breathing: Intubation if respiratory failure or severe altered mental status
2. Circulation: Large-bore IV access, fluid resuscitation
3. Disability: Assess neurologic status
4. Exposure: Identify source of shock, prevent hypothermia

Fluid Resuscitation Strategy

Shock Recognition | v 30 mL/kg crystalloid bolus over 1 hour | v Reassess: BP, perfusion, urine output, lactate | +---+---+ | | v v Improved No improvement | | v v Continue Additional fluids based on monitoring dynamic assessment | | v v Maintain Consider vasopressors if: MAP >65 - MAP <65 despite fluids - Signs of fluid overload

Vasopressor Selection & Dosing

[KEY_CONCEPT] First-line vasopressor choice depends on shock etiology and hemodynamic profile:

Septic Shock Management (Surviving Sepsis Campaign 2021)

Hour 1 Bundle:

• Measure lactate level
• Obtain blood cultures before antibiotics
• Administer broad-spectrum antibiotics
• Begin rapid administration of 30 mL/kg crystalloid for hypotension or lactate ≥4 mmol/L
• Apply vasopressors if hypotensive during or after fluid resuscitation to maintain MAP ≥65 mmHg

[HIGH_YIELD] Norepinephrine is the first-line vasopressor for septic shock per 2021 guidelines.

Cardiogenic Shock Management

Pharmacologic Support:

• Dobutamine: 2.5-20 μg/kg/min (positive inotrope)
• Milrinone: 0.375-0.75 μg/kg/min (inodilator)
• Norepinephrine: If concurrent vasodilation

Mechanical Circulatory Support:

• Intra-aortic balloon pump (IABP): Reduces afterload, improves coronary perfusion
• Impella: Percutaneous left heart assist device
• ECMO: Extracorporeal membrane oxygenation for refractory shock

[CLINICAL_PEARL] Early revascularization within 90 minutes improves outcomes in cardiogenic shock due to STEMI.

Hypovolemic Shock Management

Hemorrhagic Shock:

• Massive transfusion protocol (1:1:1 ratio of RBC:FFP:platelets)
• Target hemoglobin 7-9 g/dL unless active bleeding
• Tranexamic acid within 3 hours of trauma
• Damage control surgery principles

Non-hemorrhagic:

• Balanced crystalloids preferred over normal saline
• Avoid excessive fluid in heart failure or AKI
• Address underlying cause (GI losses, burns, etc.)

Acute Complications of Shock

Multi-Organ Dysfunction Syndrome (MODS)

[HIGH_YIELD] Sequential Organ Failure Assessment (SOFA) Score tracks organ dysfunction:

Cardiovascular Complications

• Arrhythmias: Atrial fibrillation, ventricular tachycardia
• Myocardial ischemia: Supply-demand mismatch
• Cardiac arrest: End-stage shock manifestation
• Thromboembolism: Increased risk with prolonged immobility

Respiratory Complications

Acute Respiratory Distress Syndrome (ARDS):

• Berlin criteria: Bilateral infiltrates, PaO₂/FiO₂ <300, PEEP ≥5 cm H₂O
• [CLINICAL_PEARL] Low tidal volume ventilation (6 mL/kg IBW) improves mortality per ARDS Network trial
• Prone positioning for 16+ hours daily in severe ARDS (PROSEVA trial)

Renal Complications

Acute Kidney Injury (AKI):

• KDIGO criteria: ↑ Creatinine ≥0.3 mg/dL or 1.5× baseline
• Oliguria: <0.5 mL/kg/hr for 6+ hours
• Renal replacement therapy indications: Severe acidosis, hyperkalemia, uremia, fluid overload

Neurologic Complications

• Hypoxic-ischemic encephalopathy: Prolonged hypotension
• Delirium: ICU-acquired delirium per PADIS guidelines
• Critical illness polyneuropathy: Prolonged ICU stay

Monitoring Strategies

Hemodynamic Targets

• Mean arterial pressure: ≥65 mmHg (individualize based on baseline)
• Central venous pressure: 8-12 mmHg (mechanical ventilation)
• Lactate clearance: ≥20% reduction from baseline
• Mixed venous oxygen saturation: >65%
• Urine output: >0.5 mL/kg/hr

[KEY_CONCEPT] Lactate clearance is more important than absolute lactate value for prognosis.

Advanced Monitoring Considerations

• Transpulmonary thermodilution: PiCCO system for extravascular lung water
• Bioimpedance: Non-invasive cardiac output monitoring
• Near-infrared spectroscopy (NIRS): Tissue oxygen saturation monitoring
• Sublingual capnometry: Microcirculatory assessment

Mortality Risk Stratification

Shock-Specific Mortality Rates

• Hypovolemic shock: 10-30% (depends on cause and rapidity of treatment)
• Cardiogenic shock: 40-50% (highest mortality among shock types)
• Septic shock: 25-40% (improved with early recognition and treatment)
• Anaphylactic shock: <1% with prompt epinephrine administration

[HIGH_YIELD] Time to treatment is the most critical prognostic factor across all shock types.

Prognostic Scoring Systems

APACHE II Score (Acute Physiology and Chronic Health Evaluation):

• Predicts ICU mortality
• Incorporates age, chronic health, and 12 physiologic variables
• Score >25 associated with >50% mortality

SAPS III (Simplified Acute Physiology Score):

• More contemporary scoring system
• Better calibration for modern ICU populations
• Includes admission diagnosis and comorbidities

Septic Shock Outcomes

Early Goal-Directed Therapy (EGDT) Limitations:

• Recent trials (ProCESS, ARISE, ProMISe) showed no mortality benefit
• Focus shifted to early recognition and appropriate antibiotics
• [CLINICAL_PEARL] Hour-1 bundle compliance correlates with improved survival

Long-term Sequelae:

• Post-intensive care syndrome (PICS): Cognitive, physical, and psychiatric impairments
• Chronic kidney disease: 25% develop CKD after AKI
• Cardiovascular events: Increased MI and stroke risk

Cardiogenic Shock Outcomes

Factors Associated with Improved Survival:

• Age <65 years
• Absence of multiorgan failure
• Successful revascularization
• Mechanical circulatory support when appropriate

SHOCK Trial Results:

• Early revascularization reduces 6-month mortality (50.3% vs 63.1%)
• Greatest benefit in patients <75 years old

Quality Metrics and Bundles

Sepsis Bundle Compliance:

• 3-hour bundle: Blood cultures, antibiotics, lactate measurement
• 6-hour bundle: Fluid resuscitation, vasopressor initiation
• [KEY_CONCEPT] Each hour delay in antibiotic administration increases mortality by 7.6%

Hemodynamic Optimization Goals:

• Lactate normalization within 24 hours
• Adequate urine output restoration
• Resolution of organ dysfunction markers
• Weaning of vasoactive medications

Rehabilitation and Recovery

ICU Liberation Bundle (ABCDEF):

• Assess, prevent, and manage pain
• Both spontaneous awakening and breathing trials
• Choice of analgesia and sedation
• Delirium assessment and management
• Early mobility and exercise
• Family engagement and empowerment

[CLINICAL_PEARL] Early mobility within 72 hours of ICU admission reduces length of stay and improves functional outcomes per PADIS guidelines.